MIJ821 for treatment-resistant depression
This study is completed in the United States, in Japan, in Poland, .... It is testing MIJ821 for treatment-resistant depression.
Multiple locations, including Birmingham
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in the United States, in Japan, in Poland, .... It is testing MIJ821 for treatment-resistant depression.
Multiple locations, including BirminghamThis summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Miami LakesThis study is completed in the United States, in Australia, in the United Kingdom, .... It is testing EVP-6124 (Alpha-7 nAChR) for schizophrenia.
Multiple locations, including PhoenixvilleThis study exists to see whether the medication Experience can play a useful role in care. Researchers are trying to understand whether the medication Experience can better support energy, concentration, and everyday functioning.
In BaodingThis summary needs review. Please check the official study record and contact the research team for details.
In ParisThis summary needs review. Please check the official study record and contact the research team for details.
In MunichThis summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listedThis summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listedThis study is completed in the United States. It is testing Flexible Doses of the Triple Reuptake Inhibitor EB-1020 Sustained Release (SR) for ADHD.
Multiple locations, including BradentonThis summary needs review. Please check the official study record and contact the research team for details.
In ToulouseThis summary needs review. Please check the official study record and contact the research team for details.
In BethesdaThis study exists to explore whether the medication Icariin could improve care and understanding. Researchers are trying to understand whether the medication Icariin can improve attention, thinking, or day-to-day functioning.
In DallasHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.